MEDI-534
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MEDI-534, covering 2007-07-03 to 2014-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants [Phase 1, Phase 2]